Normal Healthy Volunteers Clinical Trial
Official title:
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics of Minocin® (Minocycline) for Injection in Healthy Adult Subjects
This was a Phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study of the safety, tolerability, and pharmacokinetics of Minocin (minocycline) for injection in healthy adult participants.
The purpose of this study was to collect safety, tolerability, and pharmacokinetic (PK) data on ascending dose regimens of Minocin (minocycline) for Injection. The safety, tolerability, and PK data was to support the compound as a potential clinical candidate in Europe and allow recommendations of dose levels to be used in future Phase 2/3 studies. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05019950 -
Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers
|
Phase 1 | |
Completed |
NCT01366339 -
Tolerance and Pharmacokinetics Study of MNTX Tablets
|
Phase 1 | |
Completed |
NCT01862835 -
Impact of Estradiol Addback
|
Phase 1 | |
Completed |
NCT01629446 -
Lofexidine Mass Balance in Volunteers
|
Phase 1 | |
Completed |
NCT02026973 -
Impact of Endogenous E2 on SSI and GH Rebound
|
Phase 1 | |
Completed |
NCT03860571 -
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
|
Phase 1 | |
Recruiting |
NCT03234504 -
Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display
|
||
Completed |
NCT04188730 -
A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution
|
Phase 1 | |
Completed |
NCT02271282 -
Estradiol-Receptor Blockade in Older Men and Women
|
Phase 1 | |
Withdrawn |
NCT03291158 -
Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
|
Phase 1 |